These results suggest that miR-497 may inhibit angiogenesis and tumor growth by reducing VEGF-A and VEGFR-2 expression through PI3K/AKT and mitogen-activated protein kinase (MAPK)/ERK pathways. Here, VEGFA is linked to neoplasm.